[#DIV28SUPER] Doing Human Subject Research? Changing NIH Policies May Impact You.

If you are doing human subject research, please read about NIH changing policies regarding human subject research below.

 

 

 

Doing Human Subjects Research?

       Changing NIH Policies May Impact You

Does your study…

 

� Involve one or more human subjects?

�

 

�

� Have a health-related biomedical or behavioral outcome?

 

If “yes” to ALL of these questions, your study is considered a clinical trial.

 

Unsure how to answer the questions? We have a tool that can help!

                     https://grants.nih.gov/ct-decision/index.htm

 

 

 

 

 

Want more information?

https://grants.nih.gov/policy/clinical-trials.htm

 

 The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov   301-435-1309

 

[#DIV28SUPER] Fwd: Latest SR post on FDA shutdown of nicotine study

 

https://speakingofresearch.com/2018/01/31/the-curious-case-of-catheter-removals-at-the-fda/

 

Begin forwarded message:

From: "Panicker, Sangeeta" <spanicker@apa.org>
Date: January 31, 2018 at 11:56:12 AM EST
To: ...
Subject: Latest SR post on FDA shutdown of nicotine study

Hi Everyone—

Please share this post, which is based on a thorough analysis of the documents that were made public with reference to the shutdown of the monkey nicotine study at the NCTR.

Thanks.

--s

 

https://speakingofresearch.com/2018/01/31/the-curious-case-of-catheter-removals-at-the-fda/

 

 

Sangeeta Panicker

Director, Research Ethics, Science Directorate

American Psychological Association

 

750 First Street NE, Washington DC  20002-4242

202-336-6000

 

[#DIV28SUPER] Environmental health scientist pioneer behavior toxicology

A superb remembrance

http://www.ehn.org/pioneer-of-environmental-health-science-2529673191.html


Sent from my iPhone

_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 subscribers corner: http://lists.apa.org

[#DIV28SUPER] NYTimes: Citing Deaths of Lab Monkeys, F.D.A. Ends an Addiction Study

The agency said on Friday it was evaluating other animal studies and would retire the remaining monkeys to a sanctuary.

(Veterinary problems.. stop the research?)

Read More...

Get The New York Times on your mobile device

Sent from my iPhone

[#DIV28SUPER] URMC Professor Emeritus and Pioneer of Neurotoxicology Dies at 92 - Newsroom - University of Rochester Medical Center

https://www.urmc.rochester.edu/news/story/5221/urmc-professor-emeritus-and-pioneer-of-neurotoxicology-dies-at-92.aspx


Sent from my iPhone
_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 subscribers corner: http://lists.apa.org

[#DIV28SUPER] Fwd: NIDILRR seeks information on Opioid Use Disorder among people with disabilities

FYI...

 

From: NIDILRR Announcements [mailto:NIDILRR-announcements@naric.com]
Sent: Tuesday, January 23, 2018 1:53 PM
To: mameade@umich.edu
Subject: NIDILRR seeks information on Opioid Use Disorder among people with disabilities

 

Request for Information: Opioids and People with Disabilities

The National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) released a Request for Information (RFI) about opioids and people with disabilities.

NIDILRR is seeking input on the following areas related to the opioid public health emergency and people with disabilities. People with disabilities often experience chronic pain and, as a result, sometimes use opioids to address their pain. NIDILRR is interested in understanding: 1) whether people with disabilities have been diagnosed and are being treated for an opioid use disorder, and 2) are clinics or community organizations observing a sizeable population of people with disabilities seeking treatment for opioid use disorder? If so, are current treatment strategies adequate and, if applicable, how is your organization adapting treatment strategies for people with disabilities?

NIDILRR is issuing this RFI to obtain input on the incidence of opioid use disorder among people with disabilities. This information will help NIDILRR determine what research might be needed to inform interventions and/or policies to mitigate the effects of opioid use disorder on people with disabilities. Topics of particular interest include opioid use among common subgroups of people with disabilities and their secondary conditions, and/or the effectiveness of existing or adapted treatment strategies for opioid use disorder among people with disabilities.

Please visit the link for more details about the RFI and the process to submit comments. Comments must be submitted by February 20, 2018.

Manage Your Subscription

This message was sent to mameade@umich.edu from NIDILRR-announcements@naric.com

NIDILRR Announcements
HeiTech Services, Inc.
8400 Corporate Drive, Suite 500
Landover, MD 20785

**********************************************************
Electronic Mail is not secure, may not be read every day, and should not be used for urgent or sensitive issues

Click on this link to unsubscribe from this list UNSUBSCRIBE

An email will automatically open with "Unsubscribe" in the subject area. Just Send the message, as is, to unsubscribe from this list..

**********************************************************
Electronic Mail is not secure, may not be read every day, and should not be used for urgent or sensitive issues

[#DIV28SUPER] position at VCU

Position Opening for Assistant/Associate Professor

Center for Transformative Research on Health Behaviors (CTRHB)

Virginia Tech Carilion Research Institute

 

Position Summary:

Virginia Tech invites applications for a tenure-track faculty for the rank of Assistant Professor or Associate Professor. This position will have academic homes in a department of Virginia Tech. We seek individuals with active research programs focused on health behaviors to join the Virginia Tech Carilion Research Institute's Center for Transformative Research on Health Behaviors (CTRHB; https://ctrhb.vtc.vt.edu). The mission of the CTRHB is to conduct and disseminate transformative health behaviors research with the primary objective of preventing and treating lifestyle-related disease. Competitive salary, space and start-up packages will be provided

The Center for Transformative Research on Health Behaviors is looking for a health behavior researcher studying behavioral economics, neuroeconomics, obesity, diabetes and related diseases. For this position, we especially encourage applications from those whose research can complement existing strengths at the VTCRI in decision-making, cognitive neuroscience and the science of behavior change. Expectations include obtaining external funding, mentoring postdoctoral, doctoral, masters, and undergraduate level research trainees. The successful candidate will have a doctorate, postdoctoral training experience and a demonstrated track record of successful research related to health behavior, with strong potential for developing an extramurally funded innovative research program.

The Virginia Tech Carilion Research Institute represents a successful public-private partnership between the Commonwealth of Virginia's leading research-intensive university – Virginia Tech – and a major health care system – Carilion Clinic, in Roanoke, VA. The research institute and medical school are located in the picturesque Roanoke Valley midway between Washington DC and Charlotte, NC. The VTCRI currently houses 25 independent research groups with over 250 research and support team members and over $70M in current active extramural research funding. Prospective faculty members can draw from an outstanding and diverse pool of graduate students to work with them in their research program. VT has over 6,000 graduate students and offers graduate programs in many disciplines related to health behaviors, including as a major focus area in the Human Nutrition, Foods, and Exercise (HNFE) as well as Translational Biology, Medicine and Heath (TBMH) programs. Applicants will also enjoy access to unique shared research facilities at the VTCRI including a DXA scanner, multiple MRIs, human and animal behavioral testing and molecular biology facilities.

Required Qualifications:

• The successful candidate will have a doctorate and postdoctoral training experience. 
• Successful applicant must have demonstrated a track record of successful research related to Health Behaviors, Public Health or related field with a strong potential of developing innovative research programs that can attract sustained extramural funding. 
• Demonstrated ability to publish high quality publications;
• The ability to work independently and collaboratively on research with others;
• Excellent communication skills; and
• Commitment to quality student education.

How to Apply:

Applications will be reviewed continuously until the position is filled. It is expected that initial interviews will begin in January 2018. To apply, please submit your application including curriculum vitae, detailed statement of research accomplishments and interests and teaching/mentoring philosophy at www.jobs.vt.edu posting TR0170217. Additionally, please submit at least three reference letters online. For additional information, please contact the search committee chair – Dr. Warren K. Bickel, wkbickel@vtc.vt.edu.

Link for VT Job: https://listings.jobs.vt.edu/postings/82208

Link for CTRHB: https://ctrhb.vtc.vt.edu/

 

 

 

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684

Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
Component Lead
Research Methods
University of Kentucky Center for Clinical and Translational Science

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

[#DIV28SUPER] Bernard Weiss (1925-2018)

Bernie Weiss died this morning as a result of a fall last week. A stellar research scientist in behavioral pharmacology, he was the fifth president of the APA division of Psychopharmacology.  

Recruited to Rochester after Harold Hodge MD realized they needed professional expertise to address the behavioral consequences of exposure to toxicants (triggered by inorganic mercury vapor exposures during the Manhattan project), modern behavioral toxicology emerged from the Weiss and Laties laboratory.

An imaginative and creative scientist, Bernie inspired many research endeavors while bringing broad attention to multiple problems of environmental and occupational toxicology.

His family encourages gifts to the University of Rochester Bernard Weiss Endowment Fund supporting the Weiss Toxicology Scholar Award for pre-doctoral and postdoctoral trainees. 

https://www.urmc.rochester.edu/environmental-medicine/weiss-endowment-fund.aspx

Ron

Sent from my iPhone

[#DIV28M] Fwd: Fw: Public Health Consequences of E-Cigarettes: Report Release on January 23

Dear Colleagues,

 

The National Academies of Science, Engineering, and Medicine's report on electronic cigarettes, sponsored by the FDA, will be released on Tuesday, January 23.  You are welcome to attend a webinar at 11 am on Jan. 23 to hear the report's conclusions. Details are below.   

 

A Symposium at the upcoming SRNT Annual Meeting will summarize the findings of the report, with presentations from report authors.  Mitch Zeller of FDA will serve as a discussant.  The Symposium presentation will be on Thursday, Feb. 22, 10.30-noon.

Best,

Adam

---------- Forwarded message ---------
From: Stratton, Kathleen <KStratton@nas.edu>
Date: Thu, Jan 11, 2018 at 10:41 AM
Subject: Fw: Public Health Consequences of E-Cigarettes: Report Release on January 23
To: Adam Matthew Leventhal <adam.leventhal@usc.edu>, Ana Navas-Acien <an2737@cumc.columbia.edu>, Anthony J. Alberg <alberg@mailbox.sc.edu>, David L. Eaton <deaton@uw.edu>, David Mendez <dmendez@umich.edu>, David Savitz <david_savitz@brown.edu>, Gideon St. Helen <noedig912@gmail.com>, Jose Manautou <jose.manautou@uconn.edu>, Kent Pinkerton <kepinkerton@ucdavis.edu>, Maciej Goniewicz <maciej.goniewicz@roswellpark.org>, Nancy Rigotti <nrigotti@partners.org>, Richard Miech <rmiech@gmail.com>, Sharon McGrath-Morrow <smcgrath@jhmi.edu>

Please feel free to forward to whomever you think might be interested.

---

From: NASEM Health and Medicine <HMDnews-list=nas.edu@mail188.atl101.mcdlv.net> on behalf of NASEM Health and Medicine <HMDnews-list@nas.edu>
Sent: Thursday, January 11, 2018 10:36 AM
To: Stratton, Kathleen
Subject: Public Health Consequences of E-Cigarettes: Report Release on January 23

 

Attend our online release event, register today!

View this email in your browser   Health and Medicine Public Health Consequences of E-Cigarettes: Report Release On January 23, 2018 at 11:00 AM ET, six members from the Committee on the Review of the Health Effects of Electronic Nicotine Delivery Systems (ENDS) will present via webinar the findings of its report on public health consequences of e-cigarettes, which will be available online at the same time. The committee was convened to evaluate the available evidence of health effects related to the use of e-cigarettes/ENDS and identify future federally funded research needs. The committee will present on specifics of the report, including the role of e-cigarettes in smoking initiation and cessation, short- and long- term health effects in users and non-users, and research that should be a priority for federal funding.  Register now to view the live webinar.   Register Here Spread the word:  Tweet about it: Register now for the 1/23 NASEM report release webinar on public health consequences of e-cigarettes. http://bit.ly/ecighealthwebinar #eCigHealthEffects   Share it on Facebook: On January 23 at 11 am ET, the National Academies of Sciences, Engineering, and Medicine will release a report on the consequences of e-cigarettes for public health. Register now to watch the webinar: http://bit.ly/ecighealthwebinar #eCigHealthEffects Want more emails like this? Sign up for all of our emails on this topic. National Academies of Sciences, Engineering, and Medicine View this email in your browser Copyright © 2018 National Academy of Sciences, All rights reserved. You are receiving this because you opted in to get emails from the Health and Medicine Division. Our mailing address is: 500 Fifth Street NW Washington, DC 20001 As of March 2016, the Health and Medicine Division continues the consensus studies and convening activities previously undertaken by the Institute of Medicine (IOM). Visit us at http://nationalacademies.org/HMD If you no longer want to receive emails from this list, update your subscription preferences. If you no longer want to receive any email updates from the Health and Medicine Division, unsubscribe.

--

--
Adam Leventhal, Ph.D.
Director, USC Health, Emotion, & Addiction Laboratory
Professor of Preventive Medicine and Psychology
Keck School of Medicine
University of Southern California
2250 Alcazar St, CSC 271
Los Angeles, CA 90033
323-442-8222
heal.usc.edu

_____________________________ div28m@lists.apa.org
restricted to APA members list archive
twitter: @apadiv28

[#DIV28SUPER] Neuroscience Information Framework Webinar Research Resourch Series Continues: Friday, Jan 19, 2018

The Neuroscience Information Framework https://neuinfo.org/ invites you to join a webinar series about various research resources on the web.  Please put these down on your calendar.  We hope to hold these weekly every Friday at 2PM EST.  Future webinars to be announced and not listed here will be posted to https://neuinfo.org/about/UpcomingWebinars.  Please note that some Fridays in the holiday season will not be scheduled for webinars.  NIF is supported by U24DA039832.

 

 

Introducing The NIDA Core Center Of Excellence In Omics, Systems Genetics, And The Addictome, Dr. Rob Williams

 

Friday, January 19, 2018,

Start Time: 11 AM PST / 2 PM EST.

 

Synopsis: Technical and computational barriers prevent researchers and clinicians from incorporating more powerful genomic methods in addiction research. The purpose of the new NIDA P30 Core Center of Excellence in Omics, Systems Genetics, and the Addictome is to empower researchers to analyze genetic, epigenetic and environmental causes of drug abuse risk, relapse, and treatment. We are doing this by assembling many omics resources—primarily for rat, mouse and human—that can give investigators mechanistic and behavioral insights into addiction. In addition, we provide local workshops in systems genetics and advanced computational/statistical modeling for NIDA research teams.

To Join: At the time of the conference click this link https://uchealth.zoom.us/j/804587924

 

 

Recorded Webinars:

 

RRIDs, what are they good for and how do I use them, Drs. Anita Bandrowski and Maryann Martone

 

Friday, September 15, 2017,

Youtube Link: https://youtu.be/nzy6A5v1-gM

 

Neuroimaging Informatics Tools And Resources Clearinghouse (NITRC), Dr. David Kennedy

 

Friday, September 22, 2017,

Youtube Link: https://youtu.be/mpw6N9iZjfU

 

The Neuroscience Gateway, Subhashini Sivagnanam

 

Friday, September 29, 2017,

Youtube Link: https://youtu.be/2O7AstGdQUo

 

Cell-Type Resolved Gene Expression And Its Applications To Neuroscience With NeuroExpresso, Dr. Paul Pavlidis

 

Friday, October 06, 2017,

Youtube Link: https://youtu.be/kIxjBj-Y0xY

 

NIF And DkNET, Making Research Tools FAIR! Dr. Jeffrey Grethe

 

Friday, October 13, 2017,

Youtube Link: https://youtu.be/H0CAXbrvBDo

 

The World Of NeuroMorpho.Org, Dr. Rubén Armañanzas

 

Friday, October 20, 2017,

Youtube Link: https://youtu.be/ubLNSVD8rBk

 

NeuroML, Dr. Sharon Crook

 

Friday, October 27, 2017,

Youtube Link: https://youtu.be/bGeilKVTajk

 

The Human Connectome Project (HCP): Sharing Neuroimaging Advances, Data, And Tools, Dr. Jennifer Elam

 

Friday, November 03, 2017,

Youtube Link: https://youtu.be/uGSgmY8IJ2M

 

Mutant Mouse Resource & Research Centers (MMRRC) National Consortium, Dr. Kent Lloyd, DVM, PhD

 

Friday, November 10, 2017,

Youtube Link: https://youtu.be/IpevlgQetVE

 

Hypothes.is: Creating A Light-Weight, Open, Portable Knowledge Layer Over Biomedicine, Dr. Maryann Martone

 

Friday, December 08, 2017,

Youtube Link: https://youtu.be/aR7RJOfjGJs

 

Future and subsequent webinars TBA

 

 The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov   301-435-1309

 

[#DIV28SUPER] Addiction Psychology Postdoctoral Position Available 2018-2019 - Naperville, IL

Hi folks,

I'm happy to announce a postdoctoral position available for the 2018-2019 training year, working with me at Linden Oaks and Edward-Elmhurst Health.  This position would be based primarily in our IOP/PHP treatment clinic in Naperville, IL but options would exist to gain exposure to levels of care across the addiction spectrum that Linden Oaks provides, including medically-managed detoxification, ASAM Level 1 medication-assisted therapy, and residential care.  The postdoctoral fellow would also have the option to work with me on program-development tasks that would impact multiple clinics in Linden Oaks' outpatient network, as well as contribute to and learn about broader system-level initiatives addiction and chemical-dependency initiatives in Edward-Elmhurst Health, such as shaping opioid prescribing policy and education for physicians, improving Emergency Department responsiveness and clinical competence related to patients presenting with concerns related to addiction, among other projects.

The postdoctoral fellow could anticipate that they will complete their year having received a solid foundation for evidence-based practice in the treatment of addiction, as well as strong experience in interacting with, and shaping policy for, larger healthcare systems through collaboration with medical staff, and business administration, and project-specific workgroups. 

In addition to training experiences available directly with me, the fellow would participate in the weekly 4-hour didactic seminar and supervision series for psychology trainees, which focuses on evidence-based treatment, current professional issues, and clinical supervision.

If you know of any prospective trainees looking for a highly-focused postdoctral experience in evidence-based treatment for addiction and promoting addiction care/policy in healthcare systems, please have them send me their CV at aaron.weiner@eehealth.org.

Best regards,

Aaron

--

Aaron Weiner, PhD
Licensed Clinical Psychologist

Director, Addiction Services

Edward-Elmhurst Health

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28